A

Absence of a Chlamydia trachomatis variant, harbouring a deletion in the cryptic plasmid, in clients of a sexually transmissible infection clinic and antenatal patients in Melbourne; 77–81

ACIR
     See: Childhood immunisation coverage

Acute flaccid paralysis
     See: Poliomyelitis

Adverse events following immunisation
     annual report, 2007; 371–387

AIDS
     See: HIV and AIDS

An evaluation of the Australian Rotavirus Surveillance Program; 326–332

Annual report
     See: Individual surveillance programs

An outbreak of Clostridium perfringens and the enforcement of food safety standards; 462–465

Anthrax
     See also: Communicable diseases surveillance: tables

Arbovirus infection
     See individual diseases

ASPREN
     See: Australian Sentinel Practice Research Network

Australian bat lyssavirus
     See: Rabies

Australian Childhood Immunisation Register
     See: Childhood immunisation coverage

Australian Gonococcal Surveillance Programme
     annual report, 2007; 227–231

quarterly surveillance report; 118–119, 359–360, 490–492
     surveillance data in CDI explanation; 135
     See also: Gonococcal infection

Australian Meningococcal Surveillance Programme
     annual report, 2007; 299–307

quarterly surveillance report; 292, 364, 492
     surveillance data in CDI explanation; 135
     See also: Meningococcal infection

Australian Mycobacterium Reference Laboratory Network
     See also: Tuberculosis

Australian National Creutzfeldt-Jakob Disease Registry
     See also: Creutzfeldt-Jakob disease

Australian National Poliovirus Reference Laboratory
     annual report, 2007; 308–315
     See also: Poliomyelitis

Australian Paediatric Surveillance Unit
     annual report, 2006; 52–56
     annual report, 2007; 430–434
     enhanced surveillance for serious complications of influenza in children: role of the Australian Paediatric Surveillance Unit; 71–76
     surveillance data in CDI explanation; 135

Australian Rotavirus Surveillance Program
     annual report, 2007/08; 425–429
     evaluation; 326–332
     See also: Rotavirus

Australian Sentinel Practice Research Network
     quarterly surveillance report; 117–118, 287–288, 356–357, 487–488
     surveillance data in CDI explanation; 135–136

Australia's notifiable diseases status, 2006: annual report of the National Notifiable Diseases Surveillance System; 139–207

Avian influenza
     See: Influenza

Top of page

B

Barmah Forest virus infection
     surveillance report; 273
     See also: Communicable diseases surveillance: tables

BCG
     See: Tuberculosis

Bird flu
     See: Avian influenza

Bloodborne diseases
     surveillance report; 342
     See also:     individual diseases and Communicable diseases surveillance: tables

Botulism
     See: Communicable diseases surveillance: tables

Bovine spongiform encephalopathy
     See: Creutzfeldt-Jakob disease

Brucellosis
     See: Communicable diseases surveillance: tables

Top of page

C

Campylobacter
     See: Campylobacteriosis

Campylobacteriosis
     See: Communicable diseases surveillance: tables

Chickenpox
     See: Varicella

Chikungunya
     overseas brief; 126, 293, 365, 496

Childhood immunisation coverage
     quarterly surveillance report; 122–123, 288–289, 357–359, 488–490
     surveillance data in CDI explanation; 134–135

Chlamydia
     See: Chlamydial infection

Chlamydial infection
     Absence of a Chlamydia trachomatis variant, harbouring a deletion in the cryptic plasmid, in clients of a sexually transmissible infection clinic and antenatal patients in Melbourne; 77–81
     surveillance report; 104–116, 474
     See also: Communicable diseases surveillance: tables

Cholera
     overseas brief; 126, 365
     surveillance report; 106
     See also: Communicable diseases surveillance: tables

Clostridium perfringens, an outbreak and reinforcement of food safety standards; 462–465

Communicable Diseases Intelligence
     correction; 369
     reviewers, 2008; 498
     staff changes; 369

Communicable diseases surveillance; 104–116, 272–300, 341–372, 472–485
     See also: Individual diseases

Creutzfeldt-Jakob disease surveillance: 2008; 232–236

Cryptosporidiosis
     surveillance report; 105
     See also: Communicable diseases surveillance: tables

Top of page

D

Dengue
     overseas brief; 126–127, 293–294, 365, 496
     surveillance report; 476
     See also: Communicable diseases surveillance: tables

Diphtheria
     See: Communicable diseases surveillance: tables

Top of page

E

Ebola haemorrhagic fever
     overseas brief; 127

Emergency department syndromic surveillance public health value of, following a natural disaster; 92–94

Enhanced case detection for newly acquired hepatitis C infection: epidemiological findings and health service implications; 250–256

Enteroviruses
     See: Poliomyelitis

Epidemiology of laboratory confirmed tuberculosis in Victoria, 1990 to 2004; 237–241

Escherichia coli
     See: Shiga toxin producing Escherichia coli/verotoxin producing E. coli

Top of page

F

Flavivirus
    See:  individual diseases

Foodborne disease
     See: OzFoodNet;
     See also: individual diseases and Communicable diseases surveillance: tables

Top of page

G

Gastrointestinal diseases; 342–343
     See also: individual diseases and Communicable diseases surveillance: tables

Gonococcal infection
     Australian Gonococcal Surveillance Programme
          annual report, 2007; 227–231
          quarterly surveillance report; 118–120, 359–360, 490–492
     WHO Western Pacific Region annual report, 2006; 48–51
     See also: Communicable diseases surveillance: tables

Gonorrhoea
     See: Gonococcal infection

Top of page

H

Haemolytic uraemic syndrome
     surveillance report; 105, 342–343
     See also: Communicable diseases surveillance: tables

Haemophilus influenzae type b
     surveillance report; 343–344
    trends in type b disease in Australia, 1995–2005; 316–325
     See also: Communicable diseases surveillance: tables

Haemorrhagic fever
     See: Viral haemorrhagic fever

Hand, foot and mouth disease
     overseas brief; 365–366

Hepatitis A
     See: Communicable diseases surveillance: tables

Hepatitis B
     See: Communicable diseases surveillance: tables

Hepatitis C
    Enhanced case detection for newly acquired hepatitis C infection: epidemiological findings and health service implications; 250–256
     See also: Communicable diseases surveillance: tables

Hepatitis D
     surveillance report; 342
     See also: Communicable diseases surveillance: tables

Hepatitis E
     surveillance report; 474
     See also: Communicable diseases surveillance: tables

HIV and AIDS
     overseas brief; 294
    quarterly surveillance reports; 120–121, 360–361, 492–493
     surveillance data in CDI explanation; 136

Human papilloma virus
    Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia; 457–461
    School-based vaccinations delivered by general practice in rural north Queensland: an evaluation of a new human papilloma virus vaccination program; 94–98

Human pituary hormone
     See: Creutzfeldt-Jakob disease

Top of page

I

Immunisation
    childhood immunisation coverage
     See: Childhood immunisation coverage

Influenza
    avian
         overseas brief; 127–128, 294, 366, 496
    Enhanced surveillance for serious complications of influenza in children: role of the Australian Paediatric Surveillance Unit; 71–76
    Higher than expected seasonal influenza activity in Victoria, 2007; 63–70
    Influenza immunisation of doctors at an Australian tertiary hospital: immunisation rate and factors contributing to uptake; 443–448
    Influenza viruses with reduced sensitivity to the neuraminidase inhibitor drugs in untreated young children; 57–62
    Likely impact of school and childcare closures on public health workforce during an influenza pandemic: a survey; 261–262
    overseas brief; 295, 366, 496–497
    Prospective surveillance of excess mortality due to influenza in New South Wales: feasibility and statistical approach; 435–442
     surveillance report; 474–476
     See also: Communicable diseases surveillance: tables

Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia; 457–461

Invasive meningococcal infections
     See: Meningococcal infection
     See also: Communicable diseases surveillance: tables

Invasive pneumococcal disease
     See: Pneumococcal disease
     See also: Communicable diseases surveillance: tables

Top of page

J

Japanese encephalitis virus
     See: Communicable diseases surveillance: tables

K

Kunjin virus infection
     surveillance report; 476
     See also: Communicable diseases surveillance: tables

Top of page

L

Laboratory Virology and Serology Reporting Scheme
     surveillance data in CDI explanation; 136–137
    tables; 114–116, 284–286, 353–355, 484–486

LabVISE
     See: Laboratory Virology and Serology Reporting Scheme

Legionellosis
     See: Communicable diseases surveillance: tables

Leprosy
     See: Communicable diseases surveillance: tables

Leptospirosis
     See: Communicable diseases surveillance: tables

Likely impact of school and childcare closures on public health workforce during an influenza pandemic: a survey; 261–262

Listeriosis
     See: Communicable diseases surveillance: tables

Lyssavirus
     See: Rabies

Top of page

M

Malaria
     See: Communicable diseases surveillance: tables

Marburg haemorrhagic fever
     overseas brief; 366

Measles
     overseas brief; 295, 366–367
     surveillance report; 274–275, 344
     See also: Communicable diseases surveillance: tables

Meningococcal infection
    Australian Meningococcal Surveillance Programme
         annual report 2007; 299–307
        quarterly surveillance report; 364, 492
     surveillance report; 106–107, 276
     See also: Communicable diseases surveillance: tables

Monitoring the incidence and causes of diseases potentially transmitted by food in Australia: Annual report of the OzFoodNet Network, 2007; 400–424

Mumps
     surveillance report; 106, 344
     See also: Communicable diseases surveillance: tables

Murray Valley encephalitis virus
     surveillance report; 345
     See also: Communicable diseases surveillance: tables

Mycobacterium
     See: Tuberculosis

Top of page

N

National Arbovirus and Malaria Advisory Committee
     annual report, 2006–07; 31–47
     See also: Arbovirus infection

National Centre in HIV Epidemiology and Clinical Research
     See: HIV and AIDS

National Enteric Pathogens Surveillance System
     quarterly surveillance report; 123–125, 290–292, 362–363, 494–495
     surveillance data in CDI explanation; 137

National Influenza Surveillance Scheme
     annual report, 2007; 208–226
     surveillance data in CDI explanation; 137–138
     See also: Influenza

National Mycobacterial Surveillance Scheme
     See: Tuberculosis

National Notifiable Diseases Surveillance System
     annual report, 2006; 139–207
     surveillance data in CDI explanation; 138
     tables; 108–113, 277–283, 346–352, 477–483
     See also: Communicable diseases surveillance

Neisseria gonorrhoeae
     See: Gonococcal infection

Neisseria meningitdis
     See: Meningococcal infection

Nipah virus
     overseas brief; 296

Norwalk virus
     See: Norovirus

Norovirus outbreak associated with consumption of NSW oysters: implications for quality assurance systems; 88–91

Notifiable diseases
     See: Communicable diseases surveillance
     See also: National Notifiable Diseases Surveillance System

Notifications of enteric diseases in returning travellers who visit friends and relatives overseas: A call for action; 333–334

Top of page

O

Ornithosis
     See: Communicable diseases surveillance: tables

Oseltamivir resistance
     overseas brief; 497

Overseas brief; 126–130, 293–298, 365–368, 496–498

OzFoodNet
     annual report, 2007; 400–424
     quarterly surveillance report; 99–103, 267–271, 335–340, 469–472
     surveillance data in CDI explanation; 137

Top of page

P

Pertussis

Pertussis in infants: how to protect the vulnerable?; 449–456
     surveillance report; 344–345
     See also: Communicable diseases surveillance: tables

Plague
     overseas brief; 128, 296
     See also: Communicable diseases surveillance: tables

Plasmodium spp.
     See: Malaria

Pneumococcal disease
     annual report, 2006; 18–30
     See also: Communicable diseases surveillance: tables

Poliomyelitis
     Australian National Poliovirus Reference Laboratory annual report, 2007; 308–315
     overseas brief; 128, 296, 367, 497
     Public health value of emergency department syndromic surveillance following a natural disaster; 92–94
     What do we know about 7vpcv coverage in Aboriginal and Torres Strait Islander children? A 2007 update; 257–260
     See also: Communicable diseases surveillance: tables

Prevalence of antimicrobial resistances in Streptococcus pneumoniae in Australia, 2005; 242–249

Prospective surveillance of excess mortality due to influenza in New South Wales: feasibility and statistical approach; 435–442

Top of page

Q

Q fever
     See: Communicable diseases surveillance: tables

Quarantinable diseases
    See:  individual diseases and Communicable diseases surveillance: tables

Top of page

R

Rabies
     See: Communicable diseases surveillance: tables

Recurring outbreaks of Salmonella Typhimurium phage type 135 associated with the consumption of products containing raw egg in Tasmania; 466–468

Rift Valley fever
     overseas brief; 128–129, 367

Ross River virus infection
     surveillance report; 274, 476
     See also: Communicable diseases surveillance: tables

Rotavirus
     An evaluation of the Australian Rotavirus Surveillance Program; 326–332
     Australian Rotavirus Surveillance Program annual report, 2007/08; 425–429
     surveillance in Australia; 82–87

Rubella
     See: Communicable diseases surveillance: tables

Top of page

S

Salmonella
     See: Salmonellosis

Salmonellosis
     Recurring outbreaks of Salmonella Typhimurium phage type 135 associated with the consumption of products containing raw egg in Tasmania; 466–468
     overseas brief; 497
     See also: Communicable diseases surveillance: tables

SARS
     See: Severe acute respiratory syndrome

School-based vaccinations delivered by general practice in rural north Queensland: an evaluation of a new human papilloma virus vaccination program; 94–98
     correction; 369

Sentinel Chicken Surveillance Program
     surveillance data in CDI explanation; 138

Severe acute respiratory syndrome
     See: Communicable diseases surveillance: tables

Sexually transmissible infections
    See:  individual diseases and Communicable diseases surveillance: tables

Shiga toxin producing Escherichia coli/verotoxin producing E. coli
     See: Communicable diseases surveillance: tables

Shigellosis
     surveillance report; 474
     See also: Communicable diseases surveillance: tables

Smallpox
     See: Communicable diseases surveillance: tables

STEC
     See: Shiga toxin producing Escherichia coli/verotoxin producing E. coli

Streptococcus pneumoniae
     Prevalence of antimicrobial resistances in Streptococcus pneumoniae in Australia, 2005; 242–249

Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2006; 48–51

Surveillance of Creutzfeldt-Jakob disease in Australia: 2008; 232–236

Surveillance systems reported in CDI, 2008; 134–138

Syphilis
     See: Communicable diseases surveillance: tables

Top of page

T

Tetanus
     surveillance report; 345
     See also: Communicable diseases surveillance: tables

Trachoma surveillance annual report, 2007; 388–399

Transmissible spongiform encephalopathies
     See: Creutzfeldt-Jakob disease

Trends in invasive Haemophilus influenzae type b disease in Australia, 1995–2005; 316–325

Tuberculosis
     annual report; 1–11
     bacteriologically confirmed cases and drug resistance, 2006; 12–17
     Epidemiology of laboratory confirmed tuberculosis in Victoria, 1990 to 2004; 237–241 
     overseas brief; 129, 296–297
     See also: Communicable diseases surveillance: tables

Tularemia
     See: Communicable diseases surveillance: tables

Typhoid
     See also: Communicable diseases surveillance: tables

Top of page

U-V

Vaccination
     See: Childhood immunisation coverage

Vaccine preventable diseases
     surveillance report; 343–345
     See also  individual diseases and Communicable diseases surveillance: tables

Vaccine Preventable Diseases and Vaccination Coverage in Aboriginal and Torres Strait Islander People, Australia, 2003 to 2006; S1–S67

Varicella
    See:  individual diseases and Communicable diseases surveillance: tables

Vectorborne diseases
     surveillance report; 345
     See also: Communicable diseases surveillance: tables

Viral haemorrhagic fever
     See also: Communicable diseases surveillance: tables

Virology and Serology Laboratory Reporting Scheme
     See: Laboratory Virology and Serology Reporting Scheme

VTEC
     See: Shiga toxin producing Escherichia coli/verotoxin producing E. coli

Top of page

W

What do we know about 7vpcv coverage in Aboriginal and Torres Strait Islander children? A 2007 update; 257–260

World Health Organization gonococcal in the Western Pacific Region
     See: Gonococcal infection: WHO Western Pacific Region

X-Y

Yellow fever
     overseas brief; 297,367
     See: Communicable diseases surveillance: tables

Z

Zoonoses
    See:  individual diseases and Communicable diseases surveillance: tables